fluocinolone acetonide has been researched along with Acute Disease in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Aazami, H; Acosta, AM; Ansley, JF; Chu, L; De Valle, O; Dennis, P; Ehmer, D; Hedrick, JA | 1 |
Ansley, J; Butehorn, HF; Byers, J; Douglis, F; Esterhuizen, K; Hernández, FJ; Hussain, I; Ismail, K; Lanier, B; Lansford, B; Pumarola, F; Spektor, Z | 1 |
Rodrigo, C; Rodrigo, GJ | 1 |
Klasner, AK; Nakanishi, AK; Rubin, BK | 1 |
McFadden, ER | 1 |
Rodrigo, C; Rodrigo, G | 1 |
Eichenberger-de-Beer, H | 1 |
6 trial(s) available for fluocinolone acetonide and Acute Disease
Article | Year |
---|---|
Efficacy and Safety of Ciprofloxacin Plus Fluocinolone Acetonide Among Patients With Acute Otitis Externa: A Randomized Clinical Trial.
Topics: Acute Disease; Administration, Topical; Adult; Anti-Bacterial Agents; Ciprofloxacin; Earache; Female; Fluocinolone Acetonide; Humans; Otitis Externa | 2022 |
Efficacy and Safety of Ciprofloxacin Plus Fluocinolone in Otitis Media With Tympanostomy Tubes in Pediatric Patients: A Randomized Clinical Trial.
Topics: Acute Disease; Administration, Topical; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Female; Fluocinolone Acetonide; Humans; Infant; Male; Middle Ear Ventilation; Otitis Media; Treatment Outcome | 2017 |
Triple inhaled drug protocol for the treatment of acute severe asthma.
Topics: Acute Disease; Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchodilator Agents; Double-Blind Method; Drug Therapy, Combination; Female; Fluocinolone Acetonide; Forced Expiratory Volume; Humans; Ipratropium; Male; Prospective Studies; Steroids, Fluorinated | 2003 |
A randomized controlled trial of inhaled flunisolide in the management of acute asthma in children.
Topics: Acute Disease; Administration, Inhalation; Administration, Oral; Adolescent; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Child; Female; Fluocinolone Acetonide; Humans; Lung Volume Measurements; Male; Oxygen; Prednisone; Treatment Outcome | 2003 |
Inhaled flunisolide for acute severe asthma.
Topics: Acute Disease; Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Analysis of Variance; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Chi-Square Distribution; Double-Blind Method; Drug Administration Schedule; Emergencies; Female; Fluocinolone Acetonide; Follow-Up Studies; Forced Expiratory Volume; Glucocorticoids; Heart Rate; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Peak Expiratory Flow Rate; Placebos | 1998 |
[Therapeutic experiences with a new topical corticoid (Fluocinonid FAPG)].
Topics: Acetates; Acute Disease; Chronic Disease; Clinical Trials as Topic; Eczema; Evaluation Studies as Topic; Fluocinolone Acetonide; Humans; Lichen Planus; Neurodermatitis; Ointments; Psoriasis | 1972 |
1 other study(ies) available for fluocinolone acetonide and Acute Disease
Article | Year |
---|---|
Inhaled glucocorticoids and acute asthma: therapeutic breakthrough or nonspecific effect?
Topics: Acute Disease; Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Fluocinolone Acetonide; Forced Expiratory Volume; Genes, MHC Class II; Glucocorticoids; Humans; Microcirculation; Peak Expiratory Flow Rate; Receptors, Glucocorticoid; Transcription, Genetic; Vasoconstrictor Agents | 1998 |